-
1
-
-
77952529040
-
A position statement on NAFLD/NASH based on the EASL 2009 special conference
-
Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G: A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53: 372-384.
-
(2010)
J Hepatol
, vol.53
, pp. 372-384
-
-
Ratziu, V.1
Bellentani, S.2
Cortez-Pinto, H.3
Day, C.4
Marchesini, G.5
-
2
-
-
43049113533
-
GRADE: An emerging consensus on rating quality of evidence and strength of recommendations
-
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926.
-
(2008)
BMJ
, vol.336
, pp. 924-926
-
-
Guyatt, G.H.1
Oxman, A.D.2
Vist, G.E.3
Kunz, R.4
Falck-Ytter, Y.5
Alonso-Coello, P.6
-
3
-
-
0033982172
-
Prevalence of and risk factors for hepatic steatosis in Northern Italy
-
Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al: Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-117.
-
(2000)
Ann Intern Med
, vol.132
, pp. 112-117
-
-
Bellentani, S.1
Saccoccio, G.2
Masutti, F.3
Croce, L.S.4
Brandi, G.5
Sasso, F.6
-
4
-
-
79960029926
-
Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
-
Vernon G, Baranova A, Younossi ZM: Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 274-285
-
-
Vernon, G.1
Baranova, A.2
Younossi, Z.M.3
-
5
-
-
84869498671
-
Nonalcoholic fatty liver disease in lean individuals in the United States
-
Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al: Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine 2012; 91: 319-327.
-
(2012)
Medicine
, vol.91
, pp. 319-327
-
-
Younossi, Z.M.1
Stepanova, M.2
Negro, F.3
Hallaji, S.4
Younossi, Y.5
Lam, B.6
-
6
-
-
51349083814
-
Risk of severe liver disease in NAFLD with normal aminotransferase levels: A role for insulin resistance and diabetes
-
Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al: Risk of severe liver disease in NAFLD with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 2008; 48: 792-798.
-
(2008)
Hepatology
, vol.48
, pp. 792-798
-
-
Fracanzani, A.L.1
Valenti, L.2
Bugianesi, E.3
Andreoletti, M.4
Colli, A.5
Vanni, E.6
-
7
-
-
84918520655
-
NAFLD incidence and remission: Only a matter of weight gain and weight loss?
-
Marchesini G, Mazzotti A: NAFLD incidence and remission: only a matter of weight gain and weight loss? J Hepatol 2015; 62: 15-17.
-
(2015)
J Hepatol
, vol.62
, pp. 15-17
-
-
Marchesini, G.1
Mazzotti, A.2
-
8
-
-
84861543083
-
The diagnosis and management of nonalcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al: The diagnosis and management of nonalcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023.
-
(2012)
Hepatology
, vol.55
, pp. 2005-2023
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
Diehl, A.M.4
Brunt, E.M.5
Cusi, K.6
-
9
-
-
84888018704
-
The role of diet and nutritional intervention for the management of patients with NAFLD
-
Barrera F, George J: The role of diet and nutritional intervention for the management of patients with NAFLD. Clin Liver Dis 2014; 18: 91-112.
-
(2014)
Clin Liver Dis
, vol.18
, pp. 91-112
-
-
Barrera, F.1
George, J.2
-
10
-
-
84897993613
-
Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled feeding trials
-
Chiu S, Sievenpiper JL, de Souza RJ, Cozma AI, Mirrahimi A, Carleton AJ, et al: Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 2014; 68: 416-423.
-
(2014)
Eur J Clin Nutr
, vol.68
, pp. 416-423
-
-
Chiu, S.1
Sievenpiper, J.L.2
De Souza, R.J.3
Cozma, A.I.4
Mirrahimi, A.5
Carleton, A.J.6
-
11
-
-
84866407037
-
Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: A population-based study
-
Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, et al: Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther 2012; 36: 772-781.
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 772-781
-
-
Gerber, L.1
Otgonsuren, M.2
Mishra, A.3
Escheik, C.4
Birerdinc, A.5
Stepanova, M.6
-
12
-
-
84878930738
-
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
-
Anstee QM, Targher G, Day CP: Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013; 10: 330-344.
-
(2013)
Nat Rev Gastroenterol Hepatol
, vol.10
, pp. 330-344
-
-
Anstee, Q.M.1
Targher, G.2
Day, C.P.3
-
13
-
-
77950607738
-
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
-
Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, et al: Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1209-1217.
-
(2010)
Hepatology
, vol.51
, pp. 1209-1217
-
-
Valenti, L.1
Al-Serri, A.2
Daly, A.K.3
Galmozzi, E.4
Rametta, R.5
Dongiovanni, P.6
-
14
-
-
84902688337
-
Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
-
Liu YL, Patman GL, Leathart JB, Piguet AC, Burt AD, Dufour JF, et al: Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol 2014; 61: 75-81.
-
(2014)
J Hepatol
, vol.61
, pp. 75-81
-
-
Liu, Y.L.1
Patman, G.L.2
Leathart, J.B.3
Piguet, A.C.4
Burt, A.D.5
Dufour, J.F.6
-
15
-
-
84903708160
-
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
-
Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, et al: TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun 2014; 5: 4309.
-
(2014)
Nat Commun
, vol.5
, pp. 4309
-
-
Liu, Y.L.1
Reeves, H.L.2
Burt, A.D.3
Tiniakos, D.4
McPherson, S.5
Leathart, J.B.6
-
16
-
-
84921487729
-
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
-
Dongiovanni P, Petta S, Maglio C, Fracanzani AL, Pipitone R, Mozzi E, et al: Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology 2015; 61: 506-514.
-
(2015)
Hepatology
, vol.61
, pp. 506-514
-
-
Dongiovanni, P.1
Petta, S.2
Maglio, C.3
Fracanzani, A.L.4
Pipitone, R.5
Mozzi, E.6
-
17
-
-
77957936457
-
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
-
Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, et al: I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010; 52: 1274-1280.
-
(2010)
Hepatology
, vol.52
, pp. 1274-1280
-
-
Valenti, L.1
Alisi, A.2
Galmozzi, E.3
Bartuli, A.4
Del Menico, B.5
Alterio, A.6
-
18
-
-
84900417152
-
A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease
-
Nobili V, Donati B, Panera N, Vongsakulyanon A, Alisi A, Dallapiccola B, et al: A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2014; 58: 632-636.
-
(2014)
J Pediatr Gastroenterol Nutr
, vol.58
, pp. 632-636
-
-
Nobili, V.1
Donati, B.2
Panera, N.3
Vongsakulyanon, A.4
Alisi, A.5
Dallapiccola, B.6
-
19
-
-
20444443042
-
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
-
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al: Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906.
-
(2005)
Gastroenterology
, vol.128
, pp. 1898-1906
-
-
Ratziu, V.1
Charlotte, F.2
Heurtier, A.3
Gombert, S.4
Giral, P.5
Bruckert, E.6
-
20
-
-
84857944399
-
Nonalcoholic fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research
-
Kleiner DE, Brunt EM: Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012; 32: 3-13.
-
(2012)
Semin Liver Dis
, vol.32
, pp. 3-13
-
-
Kleiner, D.E.1
Brunt, E.M.2
-
21
-
-
20044374023
-
Design and validation of a histo-logical scoring system for nonalcoholic fatty liver disease
-
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al: Design and validation of a histo-logical scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
-
22
-
-
84904747070
-
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
-
Bedossa PFLIP Pathology Consortium
-
Bedossa PFLIP Pathology Consortium: Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology 2014; 60: 565-575.
-
(2014)
Hepatology
, vol.60
, pp. 565-575
-
-
-
23
-
-
79952231349
-
Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: Distinct clinicopathologic meanings
-
Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, Network NCR: Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011; 53: 810-820.
-
(2011)
Hepatology
, vol.53
, pp. 810-820
-
-
Brunt, E.M.1
Kleiner, D.E.2
Wilson, L.A.3
Belt, P.4
Neuschwander-Tetri, B.A.5
Network, N.C.R.6
-
24
-
-
84928209634
-
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
-
Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S, et al: Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015; 61: 1547-1554.
-
(2015)
Hepatology
, vol.61
, pp. 1547-1554
-
-
Ekstedt, M.1
Hagstrom, H.2
Nasr, P.3
Fredrikson, M.4
Stal, P.5
Kechagias, S.6
-
25
-
-
63349106888
-
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network
-
Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, et al: Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009; 49: 809-820.
-
(2009)
Hepatology
, vol.49
, pp. 809-820
-
-
Brunt, E.M.1
Kleiner, D.E.2
Wilson, L.A.3
Unalp, A.4
Behling, C.E.5
Lavine, J.E.6
-
26
-
-
84869238673
-
Development and validation of a new histo-logical score for pediatric nonalcoholic fatty liver disease
-
Alkhouri N, De Vito R, Alisi A, Yerian L, Lopez R, Feldstein AE, et al: Development and validation of a new histo-logical score for pediatric nonalcoholic fatty liver disease. J Hepatol 2012; 57: 1312-1318.
-
(2012)
J Hepatol
, vol.57
, pp. 1312-1318
-
-
Alkhouri, N.1
De Vito, R.2
Alisi, A.3
Yerian, L.4
Lopez, R.5
Feldstein, A.E.6
-
27
-
-
0036729447
-
The utility of radiological imaging in nonalcoholic fatty liver disease
-
Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al: The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
-
(2002)
Gastroenterology
, vol.123
, pp. 745-750
-
-
Saadeh, S.1
Younossi, Z.M.2
Remer, E.M.3
Gramlich, T.4
Ong, J.P.5
Hurley, M.6
-
28
-
-
23044510006
-
Hepatic MRI for fat quantitation: Its relationship to fat morphology, diagnosis, and ultrasound
-
Fishbein M, Castro F, Cheruku S, Jain S, Webb B, Gleason T, et al: Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 2005; 39: 619-625.
-
(2005)
J Clin Gastroenterol
, vol.39
, pp. 619-625
-
-
Fishbein, M.1
Castro, F.2
Cheruku, S.3
Jain, S.4
Webb, B.5
Gleason, T.6
-
29
-
-
0036911218
-
One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation
-
Ryan CK, Johnson LA, Germin BI, Marcos A: One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002;8:1114-1122.
-
(2002)
Liver Transpl
, vol.8
, pp. 1114-1122
-
-
Ryan, C.K.1
Johnson, L.A.2
Germin, B.I.3
Marcos, A.4
-
30
-
-
84908467011
-
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
-
Fedchuk L, Nascimbeni F, Pais R, Charlotte F, Housset C, Ratziu V, et al: Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2014; 40: 1209-1222.
-
(2014)
Aliment Pharmacol Ther
, vol.40
, pp. 1209-1222
-
-
Fedchuk, L.1
Nascimbeni, F.2
Pais, R.3
Charlotte, F.4
Housset, C.5
Ratziu, V.6
-
31
-
-
84876293750
-
Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
-
Machado MV, Cortez-Pinto H: Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol 2013; 58: 1007-1019.
-
(2013)
J Hepatol
, vol.58
, pp. 1007-1019
-
-
Machado, M.V.1
Cortez-Pinto, H.2
-
32
-
-
84931572246
-
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
-
European Association for the Study of the Liver, Asociacion Latinoamericana para el Estudio del Higado
-
European Association for the Study of the Liver, Asociacion Latinoamericana para el Estudio del Higado: EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015; 63: 237-264.
-
(2015)
J Hepatol
, vol.63
, pp. 237-264
-
-
-
33
-
-
84890547086
-
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
-
Cusi K, Chang Z, Harrison S, Lomonaco R, Bril F, Orsak B, et al: Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol 2014; 60: 167-174.
-
(2014)
J Hepatol
, vol.60
, pp. 167-174
-
-
Cusi, K.1
Chang, Z.2
Harrison, S.3
Lomonaco, R.4
Bril, F.5
Orsak, B.6
-
34
-
-
84891889855
-
Systematic review with meta-analysis: Non-invasive assessment of non-alcoholic fatty liver disease-the role of transient elastography and plasma cytokeratin-18 fragments
-
Kwok R, Tse YK, Wong GL, Ha Y, Lee AU, Ngu MC, et al: Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease-the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 2014; 39: 254-269.
-
(2014)
Aliment Pharmacol Ther
, vol.39
, pp. 254-269
-
-
Kwok, R.1
Tse, Y.K.2
Wong, G.L.3
Ha, Y.4
Lee, A.U.5
Ngu, M.C.6
-
35
-
-
84918770626
-
Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease
-
Vuppalanchi R, Jain AK, Deppe R, Yates K, Comerford M, Masuoka HC, et al: Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2014; 12:e2121-e2122.
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, pp. e2121-e2122
-
-
Vuppalanchi, R.1
Jain, A.K.2
Deppe, R.3
Yates, K.4
Comerford, M.5
Masuoka, H.C.6
-
36
-
-
39549118158
-
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
-
Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, et al: Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008; 47:455-460.
-
(2008)
Hepatology
, vol.47
, pp. 455-460
-
-
Guha, I.N.1
Parkes, J.2
Roderick, P.3
Chattopadhyay, D.4
Cross, R.5
Harris, S.6
-
37
-
-
84877010489
-
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
-
McPherson S, Anstee QM, Henderson E, Day CP, Burt AD: Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? Eur J Gastroenterol Hepatol 2013; 25: 652-658.
-
(2013)
Eur J Gastroenterol Hepatol
, vol.25
, pp. 652-658
-
-
McPherson, S.1
Anstee, Q.M.2
Henderson, E.3
Day, C.P.4
Burt, A.D.5
-
38
-
-
75449091784
-
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
-
Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, et al: Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-462.
-
(2010)
Hepatology
, vol.51
, pp. 454-462
-
-
Wong, V.W.1
Vergniol, J.2
Wong, G.L.3
Foucher, J.4
Chan, H.L.5
Le Bail, B.6
-
39
-
-
77950619459
-
Pitfalls of liver stiffness measurement: A 5-year prospective study of 13, 369 examinations
-
Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al: Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations. Hepatology 2010; 51: 828-835.
-
(2010)
Hepatology
, vol.51
, pp. 828-835
-
-
Castera, L.1
Foucher, J.2
Bernard, P.H.3
Carvalho, F.4
Allaix, D.5
Merrouche, W.6
-
40
-
-
84870819164
-
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease
-
Wong VW, Vergniol J, Wong GL, Foucher J, Chan AW, Chermak F, et al: Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012; 107: 1862-1871.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 1862-1871
-
-
Wong, V.W.1
Vergniol, J.2
Wong, G.L.3
Foucher, J.4
Chan, A.W.5
Chermak, F.6
-
41
-
-
84927693372
-
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease
-
Petta S, Vanni E, Bugianesi E, Di Marco V, Camma C, Cabibi D, et al: The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. Liver Int 2015; 35: 1566-1573.
-
(2015)
Liver Int
, vol.35
, pp. 1566-1573
-
-
Petta, S.1
Vanni, E.2
Bugianesi, E.3
Di Marco, V.4
Camma, C.5
Cabibi, D.6
-
42
-
-
84859970076
-
Diagnosis of nonalcoholic fatty liver disease in children and adolescents: Position paper of the ESPGHAN Hepatology Committee
-
Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al: Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastro-enterol Nutr 2012; 54: 700-713.
-
(2012)
J Pediatr Gastro-enterol Nutr
, vol.54
, pp. 700-713
-
-
Vajro, P.1
Lenta, S.2
Socha, P.3
Dhawan, A.4
McKiernan, P.5
Baumann, U.6
-
43
-
-
84877920825
-
A 360-degree overview of paediatric NAFLD: Recent insights
-
Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P: A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol 2013; 58: 1218-1229.
-
(2013)
J Hepatol
, vol.58
, pp. 1218-1229
-
-
Nobili, V.1
Svegliati-Baroni, G.2
Alisi, A.3
Miele, L.4
Valenti, L.5
Vajro, P.6
-
44
-
-
84877854022
-
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
-
Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A: Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013; 5: 1544-1560.
-
(2013)
Nutrients
, vol.5
, pp. 1544-1560
-
-
Gaggini, M.1
Morelli, M.2
Buzzigoli, E.3
DeFronzo, R.A.4
Bugianesi, E.5
Gastaldelli, A.6
-
46
-
-
84937738375
-
Adaptation of hepatic mitochondrial function in humans with nonalcoholic fatty liver is lost in steatohepatitis
-
Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, et al: Adaptation of hepatic mitochondrial function in humans with nonalcoholic fatty liver is lost in steatohepatitis. Cell Metab 2015; 21: 739-746.
-
(2015)
Cell Metab
, vol.21
, pp. 739-746
-
-
Koliaki, C.1
Szendroedi, J.2
Kaul, K.3
Jelenik, T.4
Nowotny, P.5
Jankowiak, F.6
-
47
-
-
84902672359
-
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
-
Yki-Järvinen H: Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014; 2: 901-910.
-
(2014)
Lancet Diabetes Endocrinol
, vol.2
, pp. 901-910
-
-
Yki-Järvinen, H.1
-
48
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
49
-
-
84927796763
-
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
-
McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM: Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol 2015; 62: 1148-1155.
-
(2015)
J Hepatol
, vol.62
, pp. 1148-1155
-
-
McPherson, S.1
Hardy, T.2
Henderson, E.3
Burt, A.D.4
Day, C.P.5
Anstee, Q.M.6
-
50
-
-
84882906611
-
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
-
Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, et al: A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 2013; 59: 550-556.
-
(2013)
J Hepatol
, vol.59
, pp. 550-556
-
-
Pais, R.1
Charlotte, F.2
Fedchuk, L.3
Bedossa, P.4
Lebray, P.5
Poynard, T.6
-
51
-
-
21344449292
-
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study
-
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
-
(2005)
Hepatology
, vol.42
, pp. 44-52
-
-
Bedogni, G.1
Miglioli, L.2
Masutti, F.3
Tiribelli, C.4
Marchesini, G.5
Bellentani, S.6
-
52
-
-
71149113575
-
Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease
-
Frith J, Day CP, Robinson L, Elliott C, Jones DE, Newton JL: Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol 2010; 52: 112-116.
-
(2010)
J Hepatol
, vol.52
, pp. 112-116
-
-
Frith, J.1
Day, C.P.2
Robinson, L.3
Elliott, C.4
Jones, D.E.5
Newton, J.L.6
-
53
-
-
1642355723
-
The spectrum expanded: Cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease
-
Caldwell SH, Crespo DM: The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 2004; 40: 578-584.
-
(2004)
J Hepatol
, vol.40
, pp. 578-584
-
-
Caldwell, S.H.1
Crespo, D.M.2
-
54
-
-
83555176096
-
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese
-
Aron-Wisnewsky J, Minville C, Tordjman J, Levy P, Bouillot JL, Basdevant A, et al: Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol 2012; 56: 225-233.
-
(2012)
J Hepatol
, vol.56
, pp. 225-233
-
-
Aron-Wisnewsky, J.1
Minville, C.2
Tordjman, J.3
Levy, P.4
Bouillot, J.L.5
Basdevant, A.6
-
55
-
-
84857058884
-
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity
-
Gomez-Ambrosi J, Silva C, Galofre JC, Escalada J, Santos S, Millan D, et al: Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) 2012; 36: 286-294.
-
(2012)
Int J Obes (Lond)
, vol.36
, pp. 286-294
-
-
Gomez-Ambrosi, J.1
Silva, C.2
Galofre, J.C.3
Escalada, J.4
Santos, S.5
Millan, D.6
-
56
-
-
84866353150
-
Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men
-
Chang Y, Ryu S, Suh BS, Yun KE, Kim CW, Cho SI: Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes (Lond) 2012; 36: 1187-1194.
-
(2012)
Int J Obes (Lond)
, vol.36
, pp. 1187-1194
-
-
Chang, Y.1
Ryu, S.2
Suh, B.S.3
Yun, K.E.4
Kim, C.W.5
Cho, S.I.6
-
57
-
-
84908179567
-
Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy
-
Gomez-Ambrosi J, Catalan V, Rodriguez A, Andrada P, Ramirez B, Ibanez P, et al: Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care 2014; 37: 2813-2821.
-
(2014)
Diabetes Care
, vol.37
, pp. 2813-2821
-
-
Gomez-Ambrosi, J.1
Catalan, V.2
Rodriguez, A.3
Andrada, P.4
Ramirez, B.5
Ibanez, P.6
-
58
-
-
77956631214
-
Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data
-
Ghouri N, Preiss D, Sattar N: Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010; 52: 1156-1161.
-
(2010)
Hepatology
, vol.52
, pp. 1156-1161
-
-
Ghouri, N.1
Preiss, D.2
Sattar, N.3
-
59
-
-
34547514221
-
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
-
Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al: Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007; 133: 496-506.
-
(2007)
Gastroenterology
, vol.133
, pp. 496-506
-
-
Gastaldelli, A.1
Cusi, K.2
Pettiti, M.3
Hardies, J.4
Miyazaki, Y.5
Berria, R.6
-
60
-
-
38149030206
-
Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects
-
Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Corner A, Bergholm R, et al: Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 2008; 31: 165-169.
-
(2008)
Diabetes Care
, vol.31
, pp. 165-169
-
-
Kotronen, A.1
Juurinen, L.2
Hakkarainen, A.3
Westerbacka, J.4
Corner, A.5
Bergholm, R.6
-
61
-
-
84865545850
-
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
-
Loomba R, Abraham M, Unalp A, Wilson L, Lavine J, Doo E, et al: Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012; 56: 943-951.
-
(2012)
Hepatology
, vol.56
, pp. 943-951
-
-
Loomba, R.1
Abraham, M.2
Unalp, A.3
Wilson, L.4
Lavine, J.5
Doo, E.6
-
62
-
-
84896690517
-
Extrahepatic complications of nonalcoholic fatty liver disease
-
Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014; 59: 1174-1197.
-
(2014)
Hepatology
, vol.59
, pp. 1174-1197
-
-
Armstrong, M.J.1
Adams, L.A.2
Canbay, A.3
Syn, W.K.4
-
63
-
-
84892649479
-
Standards of medical care in diabetes- 2014
-
American Diabetes Association: Standards of medical care in diabetes- 2014. Diabetes Care 2014; 37:S14-S80.
-
(2014)
Diabetes Care
, vol.37
, pp. S14-S80
-
-
Diabetes Association, A.1
-
64
-
-
84859393575
-
Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD)
-
Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, et al: Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 2012; 35: 873-878.
-
(2012)
Diabetes Care
, vol.35
, pp. 873-878
-
-
Ortiz-Lopez, C.1
Lomonaco, R.2
Orsak, B.3
Finch, J.4
Chang, Z.5
Kochunov, V.G.6
-
65
-
-
33947131149
-
Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes
-
Juurinen L, Tiikkainen M, Häkkinen AM, Hakkarainen A, Yki-Järvinen H: Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292:E829-E835.
-
(2007)
Am J Physiol Endocrinol Metab
, vol.292
, pp. E829-E835
-
-
Juurinen, L.1
Tiikkainen, M.2
Häkkinen, A.M.3
Hakkarainen, A.4
Yki-Järvinen, H.5
-
66
-
-
84922576094
-
Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes
-
Llaurado G, Sevastianova K, Sadevirta S, Hakkarainen A, Lundbom N, Orho-Melander M, et al: Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes. J Clin Endocrinol Metab 2015; 100: 607-616.
-
(2015)
J Clin Endocrinol Metab
, vol.100
, pp. 607-616
-
-
Llaurado, G.1
Sevastianova, K.2
Sadevirta, S.3
Hakkarainen, A.4
Lundbom, N.5
Orho-Melander, M.6
-
67
-
-
0036788388
-
Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle
-
Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, et al: Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 2002; 51: 3025-3032.
-
(2002)
Diabetes
, vol.51
, pp. 3025-3032
-
-
Anderwald, C.1
Bernroider, E.2
Krssak, M.3
Stingl, H.4
Brehm, A.5
Bischof, M.G.6
-
68
-
-
84924938800
-
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies
-
e641-e649; quiz e639-e640
-
Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R: Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastro-enterol Hepatol 2015; 13: 643-654, e641-e649; quiz e639-e640.
-
(2015)
Clin Gastro-enterol Hepatol
, vol.13
, pp. 643-654
-
-
Singh, S.1
Allen, A.M.2
Wang, Z.3
Prokop, L.J.4
Murad, M.H.5
Loomba, R.6
-
69
-
-
84910025836
-
Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease
-
Haflidadottir S, Jonasson JG, Norland H, Einarsdottir SO, Kleiner DE, Lund SH, et al: Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease. BMC Gastroen-terol 2014; 14: 166.
-
(2014)
BMC Gastroen-terol
, vol.14
, pp. 166
-
-
Haflidadottir, S.1
Jonasson, J.G.2
Norland, H.3
Einarsdottir, S.O.4
Kleiner, D.E.5
Lund, S.H.6
-
70
-
-
84876130551
-
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
-
Kim D, Kim WR, Kim HJ, Therneau TM: Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013; 57: 1357-1365.
-
(2013)
Hepatology
, vol.57
, pp. 1357-1365
-
-
Kim, D.1
Kim, W.R.2
Kim, H.J.3
Therneau, T.M.4
-
71
-
-
24144444669
-
Histopathology of pediatric nonalcoholic fatty liver disease
-
Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, et al: Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005;42:641-649.
-
(2005)
Hepatology
, vol.42
, pp. 641-649
-
-
Schwimmer, J.B.1
Behling, C.2
Newbury, R.3
Deutsch, R.4
Nievergelt, C.5
Schork, N.J.6
-
72
-
-
84884508163
-
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
-
Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A, et al: A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis 2013; 230: 258-267.
-
(2013)
Atherosclerosis
, vol.230
, pp. 258-267
-
-
Oni, E.T.1
Agatston, A.S.2
Blaha, M.J.3
Fialkow, J.4
Cury, R.5
Sposito, A.6
-
73
-
-
77957375969
-
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
-
Targher G, Day CP, Bonora E: Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363: 1341-1350.
-
(2010)
N Engl J Med
, vol.363
, pp. 1341-1350
-
-
Targher, G.1
Day, C.P.2
Bonora, E.3
-
74
-
-
84861417701
-
Non-alcoholic fatty liver disease: A new and important cardiovascular risk factor?
-
Bhatia LS, Curzen NP, Calder PC, Byrne CD: Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 2012; 33:1190-1200.
-
(2012)
Eur Heart J
, vol.33
, pp. 1190-1200
-
-
Bhatia, L.S.1
Curzen, N.P.2
Calder, P.C.3
Byrne, C.D.4
-
75
-
-
79959541652
-
Fatty liver index and mortality: The Cremona study in the 15th year of follow-up
-
Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, Villa M, et al: Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011; 54: 145-152.
-
(2011)
Hepatology
, vol.54
, pp. 145-152
-
-
Calori, G.1
Lattuada, G.2
Ragogna, F.3
Garancini, M.P.4
Crosignani, P.5
Villa, M.6
-
76
-
-
84905398054
-
Nonalcoholic fatty liver disease and the heart in children and adolescents
-
Pacifico L, Chiesa C, Anania C, De Merulis A, Osborn JF, Romaggioli S, et al: Nonalcoholic fatty liver disease and the heart in children and adolescents. World J Gastroenterol 2014; 20: 9055-9071.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 9055-9071
-
-
Pacifico, L.1
Chiesa, C.2
Anania, C.3
De Merulis, A.4
Osborn, J.F.5
Romaggioli, S.6
-
77
-
-
84890562275
-
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
-
Dyson J, Jaques B, Chattopadyhay D, Lochan R, Graham J, Das D, et al: Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J Hepatol 2014; 60: 110-117.
-
(2014)
J Hepatol
, vol.60
, pp. 110-117
-
-
Dyson, J.1
Jaques, B.2
Chattopadyhay, D.3
Lochan, R.4
Graham, J.5
Das, D.6
-
78
-
-
84901616858
-
Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
-
Wong RJ, Cheung R, Ahmed A: Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.. Hepatology 2014; 59: 2188-2195.
-
(2014)
Hepatology
, vol.59
, pp. 2188-2195
-
-
Wong, R.J.1
Cheung, R.2
Ahmed, A.3
-
79
-
-
84905401784
-
Association of non-alcoholic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis
-
Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, et al: Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med 2014; 11:e1001680.
-
(2014)
PLoS Med
, vol.11
-
-
Musso, G.1
Gambino, R.2
Tabibian, J.H.3
Ekstedt, M.4
Kechagias, S.5
Hamaguchi, M.6
-
80
-
-
77955665639
-
Nonalcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
-
Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, et al: Nonalcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 2010; 53: 1341-1348.
-
(2010)
Diabetologia
, vol.53
, pp. 1341-1348
-
-
Targher, G.1
Bertolini, L.2
Chonchol, M.3
Rodella, S.4
Zoppini, G.5
Lippi, G.6
-
81
-
-
84901485469
-
Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population
-
Kim NH, Park J, Kim SH, Kim YH, Kim DH, Cho GY, et al: Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart 2014; 100: 938-943.
-
(2014)
Heart
, vol.100
, pp. 938-943
-
-
Kim, N.H.1
Park, J.2
Kim, S.H.3
Kim, Y.H.4
Kim, D.H.5
Cho, G.Y.6
-
82
-
-
84880946812
-
Non-alcoholic fatty liver disease in common endocrine disorders
-
Hazlehurst JM, Tomlinson JW: Non-alcoholic fatty liver disease in common endocrine disorders. Eur J Endo-crinol 2013; 169:R27-R37.
-
(2013)
Eur J Endo-crinol
, vol.169
, pp. R27-R37
-
-
Hazlehurst, J.M.1
Tomlinson, J.W.2
-
83
-
-
1542515099
-
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
-
Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, et al: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 2004; 39: 770-778.
-
(2004)
Hepatology
, vol.39
, pp. 770-778
-
-
Lindor, K.D.1
Kowdley, K.V.2
Heathcote, E.J.3
Harrison, M.E.4
Jorgensen, R.5
Angulo, P.6
-
84
-
-
19144365586
-
A randomized controlled trial of metformin versus Vitamin E or prescriptive diet in nonalcoholic fatty liver disease
-
Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, et al: A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 1082-1090.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1082-1090
-
-
Bugianesi, E.1
Gentilcore, E.2
Manini, R.3
Natale, S.4
Vanni, E.5
Villanova, N.6
-
85
-
-
33751545838
-
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
-
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006; 355: 2297-2307.
-
(2006)
N Engl J Med
, vol.355
, pp. 2297-2307
-
-
Belfort, R.1
Harrison, S.A.2
Brown, K.3
Darland, C.4
Finch, J.5
Hardies, J.6
-
86
-
-
33646483917
-
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
-
Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, et al: A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006; 4: 639-644.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 639-644
-
-
Zelber-Sagi, S.1
Kessler, A.2
Brazowsky, E.3
Webb, M.4
Lurie, Y.5
Santo, M.6
-
87
-
-
33845336554
-
Randomized placebo-controlled trial of urso-deoxycholic acid with Vitamin E in nonalcoholic steatohepatitis
-
Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, et al: Randomized placebo-controlled trial of urso-deoxycholic acid with vitamin E in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2006; 4: 1537-1543.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 1537-1543
-
-
Dufour, J.F.1
Oneta, C.M.2
Gonvers, J.J.3
Bihl, F.4
Cerny, A.5
Cereda, J.M.6
-
88
-
-
46349088361
-
Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial
-
Ratziu V, Giral P, Jacqueminet S, Charlotte F, Hartemann-Heurtier A, Serfaty L, et al: Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology 2008; 135: 100-110.
-
(2008)
Gastroenterology
, vol.135
, pp. 100-110
-
-
Ratziu, V.1
Giral, P.2
Jacqueminet, S.3
Charlotte, F.4
Hartemann-Heurtier, A.5
Serfaty, L.6
-
89
-
-
53049101877
-
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
-
Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, et al: Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008; 135: 1176-1184.
-
(2008)
Gastroenterology
, vol.135
, pp. 1176-1184
-
-
Aithal, G.P.1
Thomas, J.A.2
Kaye, P.V.3
Lawson, A.4
Ryder, S.D.5
Spendlove, I.6
-
90
-
-
70350662659
-
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
-
Haukeland JW, Konopski Z, Eggesbo HB, von Volkmann HL, Raschpichler G, Bjoro K, et al: Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. Scand J Gastroenterol 2009; 44: 853-860.
-
(2009)
Scand J Gastroenterol
, vol.44
, pp. 853-860
-
-
Haukeland, J.W.1
Konopski, Z.2
Eggesbo, H.B.3
Von Volkmann, H.L.4
Raschpichler, G.5
Bjoro, K.6
-
91
-
-
58949102847
-
Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
-
Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA: Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 2009; 49: 80-86.
-
(2009)
Hepatology
, vol.49
, pp. 80-86
-
-
Harrison, S.A.1
Fecht, W.2
Brunt, E.M.3
Neuschwander-Tetri, B.A.4
-
92
-
-
77953368192
-
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepa-titis (NASH): A pilot trial
-
Shields WW, Thompson KE, Grice GA, Harrison SA, Coyle WJ: The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepa-titis (NASH): a pilot trial. Therap Adv Gastroenterol 2009; 2: 157-163.
-
(2009)
Therap Adv Gastroenterol
, vol.2
, pp. 157-163
-
-
Shields, W.W.1
Thompson, K.E.2
Grice, G.A.3
Harrison, S.A.4
Coyle, W.J.5
-
93
-
-
73449116035
-
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
-
Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al: Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010; 51: 121-129.
-
(2010)
Hepatology
, vol.51
, pp. 121-129
-
-
Promrat, K.1
Kleiner, D.E.2
Niemeier, H.M.3
Jackvony, E.4
Kearns, M.5
Wands, J.R.6
-
94
-
-
75449116707
-
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
-
Ratziu V, Charlotte F, Bernhardt C, Giral P, Halbron M, Lenaour G, et al: Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial. Hepatology 2010; 51: 445-453.
-
(2010)
Hepatology
, vol.51
, pp. 445-453
-
-
Ratziu, V.1
Charlotte, F.2
Bernhardt, C.3
Giral, P.4
Halbron, M.5
Lenaour, G.6
-
95
-
-
77951874018
-
Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis
-
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al: Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362: 1675-1685.
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
McCullough, A.4
Diehl, A.M.5
Bass, N.M.6
-
96
-
-
77955699301
-
High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: A double-blind, randomized, placebo-controlled trial
-
Leuschner UF, Lindenthal B, Herrmann G, Arnold JC, Rossle M, Cordes HJ, et al: High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. Hepatology 2010;52:472-479.
-
(2010)
Hepatology
, vol.52
, pp. 472-479
-
-
Leuschner, U.F.1
Lindenthal, B.2
Herrmann, G.3
Arnold, J.C.4
Rossle, M.5
Cordes, H.J.6
-
97
-
-
80055028155
-
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
-
Zein CO, Yerian LM, Gogate P, Lopez R, Kirwan JP, Feldstein AE, et al: Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology 2011; 54: 1610-1619.
-
(2011)
Hepatology
, vol.54
, pp. 1610-1619
-
-
Zein, C.O.1
Yerian, L.M.2
Gogate, P.3
Lopez, R.4
Kirwan, J.P.5
Feldstein, A.E.6
-
98
-
-
79955446251
-
Effect of Vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial
-
Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, et al: Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011; 305: 1659-1668.
-
(2011)
JAMA
, vol.305
, pp. 1659-1668
-
-
Lavine, J.E.1
Schwimmer, J.B.2
Van Natta, M.L.3
Molleston, J.P.4
Murray, K.F.5
Rosenthal, P.6
-
99
-
-
84929266699
-
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multi-centre, randomised, placebo-controlled trial
-
Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, et al: Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multi-centre, randomised, placebo-controlled trial. Lancet 2015; 385: 956-965.
-
(2015)
Lancet
, vol.385
, pp. 956-965
-
-
Neuschwander-Tetri, B.A.1
Loomba, R.2
Sanyal, A.J.3
Lavine, J.E.4
Van Natta, M.L.5
Abdelmalek, M.F.6
-
100
-
-
84896470468
-
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia
-
Valenti L, Fracanzani AL, Dongiovanni P, Rovida S, Rametta R, Fatta E, et al: A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia. World J Gastroenterol 2014; 20: 3002-3010.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 3002-3010
-
-
Valenti, L.1
Fracanzani, A.L.2
Dongiovanni, P.3
Rovida, S.4
Rametta, R.5
Fatta, E.6
-
101
-
-
84898600580
-
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: A randomised controlled trial
-
Takeshita Y, Takamura T, Honda M, Kita Y, Zen Y, Kato K, et al: The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial. Diabetologia 2014; 57: 878-890.
-
(2014)
Diabetologia
, vol.57
, pp. 878-890
-
-
Takeshita, Y.1
Takamura, T.2
Honda, M.3
Kita, Y.4
Zen, Y.5
Kato, K.6
-
102
-
-
84904661185
-
No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial
-
Sanyal AJ, Abdelmalek MF, Suzuki A, Cummings OW, Chojkier M; EPE-A Study Group: No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. Gastroen-terology 2014; 147:e377-384.e1.
-
(2014)
Gastroen-terology
, vol.147
, pp. e377-e377
-
-
Sanyal, A.J.1
Abdelmalek, M.F.2
Suzuki, A.3
Cummings, O.W.4
Chojkier, M.5
-
103
-
-
84925339397
-
Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
-
Loomba R, Sirlin CB, Ang B, Bettencourt R, Jain R, Salotti J, et al: Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 2015; 61: 1239-1250.
-
(2015)
Hepatology
, vol.61
, pp. 1239-1250
-
-
Loomba, R.1
Sirlin, C.B.2
Ang, B.3
Bettencourt, R.4
Jain, R.5
Salotti, J.6
-
104
-
-
84918554640
-
Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
-
Argo CK, Patrie JT, Lackner C, Henry TD, de Lange EE, Weltman AL, et al: Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial. J Hepatol 2015; 62: 190-197.
-
(2015)
J Hepatol
, vol.62
, pp. 190-197
-
-
Argo, C.K.1
Patrie, J.T.2
Lackner, C.3
Henry, T.D.4
De Lange, E.E.5
Weltman, A.L.6
-
105
-
-
84957840942
-
Liraglutide safety and effi cacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre double-blind randomised placebo-controlled phase 2 study
-
Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, et al: Liraglutide safety and effi cacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet 2015;doi: 10.1016/S0140-6736(15)00803-X.
-
(2015)
Lancet
-
-
Armstrong, M.J.1
Gaunt, P.2
Aithal, G.P.3
Barton, D.4
Hull, D.5
Parker, R.6
-
106
-
-
80051979813
-
Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
-
Zelber-Sagi S, Ratziu V, Oren R: Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011; 17: 3377-3389.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 3377-3389
-
-
Zelber-Sagi, S.1
Ratziu, V.2
Oren, R.3
-
107
-
-
65249187315
-
High- or low-carbohydrate diets: Which is better for weight loss, insulin resistance, and fatty livers?
-
Boden G: High- or low-carbohydrate diets: which is better for weight loss, insulin resistance, and fatty livers? Gastroenterology 2009; 136: 1490-1492.
-
(2009)
Gastroenterology
, vol.136
, pp. 1490-1492
-
-
Boden, G.1
-
108
-
-
78149283488
-
Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes
-
Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, et al: Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 2010; 33: 2156-2163.
-
(2010)
Diabetes Care
, vol.33
, pp. 2156-2163
-
-
Lazo, M.1
Solga, S.F.2
Horska, A.3
Bonekamp, S.4
Diehl, A.M.5
Brancati, F.L.6
-
109
-
-
84862302415
-
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: Results from the Diabetes Prevention Program Outcomes Study
-
Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE: Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012; 379: 2243-2251.
-
(2012)
Lancet
, vol.379
, pp. 2243-2251
-
-
Perreault, L.1
Pan, Q.2
Mather, K.J.3
Watson, K.E.4
Hamman, R.F.5
Kahn, S.E.6
-
110
-
-
83555176039
-
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
-
Thoma C, Day CP, Trenell MI: Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012; 56: 255-266.
-
(2012)
J Hepatol
, vol.56
, pp. 255-266
-
-
Thoma, C.1
Day, C.P.2
Trenell, M.I.3
-
111
-
-
84879136876
-
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
-
Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al: The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013; 59: 138-143.
-
(2013)
J Hepatol
, vol.59
, pp. 138-143
-
-
Ryan, M.C.1
Itsiopoulos, C.2
Thodis, T.3
Ward, G.4
Trost, N.5
Hofferberth, S.6
-
112
-
-
84863679715
-
What should we recommend to our patients with NAFLD regarding alcohol use?
-
Liangpunsakul S, Chalasani N: What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol 2012; 107: 976-978.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 976-978
-
-
Liangpunsakul, S.1
Chalasani, N.2
-
113
-
-
84890128594
-
Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease
-
Kwon HK, Greenson JK, Conjeevaram HS: Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease. Liver Int 2014; 34: 129-135.
-
(2014)
Liver Int
, vol.34
, pp. 129-135
-
-
Kwon, H.K.1
Greenson, J.K.2
Conjeevaram, H.S.3
-
114
-
-
84863987868
-
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
-
Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, et al: Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol 2012; 57: 384-391.
-
(2012)
J Hepatol
, vol.57
, pp. 384-391
-
-
Dunn, W.1
Sanyal, A.J.2
Brunt, E.M.3
Unalp-Arida, A.4
Donohue, M.5
McCullough, A.J.6
-
115
-
-
77952730428
-
The incidence and risk factors of hepato-cellular carcinoma in patients with nonalcoholic steatohepatitis
-
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN: The incidence and risk factors of hepato-cellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972-1978.
-
(2010)
Hepatology
, vol.51
, pp. 1972-1978
-
-
Ascha, M.S.1
Hanouneh, I.A.2
Lopez, R.3
Tamimi, T.A.4
Feldstein, A.F.5
Zein, N.N.6
-
116
-
-
84895794335
-
Impact of coffee on liver diseases: A systematic review
-
Saab S, Mallam D, Cox 2nd GA, Tong MJ: Impact of coffee on liver diseases: a systematic review. Liver Int 2014; 34: 495-504.
-
(2014)
Liver Int
, vol.34
, pp. 495-504
-
-
Saab, S.1
Mallam, D.2
Cox, G.A.3
Tong, M.J.4
-
117
-
-
84862700268
-
Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
-
Keating SE, Hackett DA, George J, Johnson NA: Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012; 57: 157-166.
-
(2012)
J Hepatol
, vol.57
, pp. 157-166
-
-
Keating, S.E.1
Hackett, D.A.2
George, J.3
Johnson, N.A.4
-
118
-
-
84884984755
-
Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial)
-
Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, et al: Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology 2013; 58: 1287-1295.
-
(2013)
Hepatology
, vol.58
, pp. 1287-1295
-
-
Bacchi, E.1
Negri, C.2
Targher, G.3
Faccioli, N.4
Lanza, M.5
Zoppini, G.6
-
119
-
-
14644435731
-
Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes
-
Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI: Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005; 54: 603-608.
-
(2005)
Diabetes
, vol.54
, pp. 603-608
-
-
Petersen, K.F.1
Dufour, S.2
Befroy, D.3
Lehrke, M.4
Hendler, R.E.5
Shulman, G.I.6
-
120
-
-
84929354082
-
Weight loss via lifestyle modification significantly reduces features of nonalcoholic steatohepatitis
-
quiz e14-e15
-
Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al: Weight loss via lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastro-enterology 2015; 149: 367-378.e5; quiz e14-e15.
-
(2015)
Gastro-enterology
, vol.149
, pp. 367
-
-
Vilar-Gomez, E.1
Martinez-Perez, Y.2
Calzadilla-Bertot, L.3
Torres-Gonzalez, A.4
Gra-Oramas, B.5
Gonzalez-Fabian, L.6
-
121
-
-
84870591332
-
Physical activity: An essential component of lifestyle modification in NAFLD
-
Rodriguez B, Torres DM, Harrison SA: Physical activity: an essential component of lifestyle modification in NAFLD. Nat Rev Gastroenterol Hepatol 2012; 9: 726-731.
-
(2012)
Nat Rev Gastroenterol Hepatol
, vol.9
, pp. 726-731
-
-
Rodriguez, B.1
Torres, D.M.2
Harrison, S.A.3
-
122
-
-
11144351102
-
The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies
-
Adams LA, Sanderson S, Lindor KD, Angulo P: The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-138.
-
(2005)
J Hepatol
, vol.42
, pp. 132-138
-
-
Adams, L.A.1
Sanderson, S.2
Lindor, K.D.3
Angulo, P.4
-
123
-
-
84925374835
-
Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
-
American Association for the Study of Liver Diseases United States Food and Drug Administration
-
Sanyal AJ, Friedman SL, McCullough AJ, Dimick-Santos L; American Association for the Study of Liver Diseases, United States Food and Drug Administration: Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. Hepatology 2015; 61: 1392-1405.
-
(2015)
Hepatology
, vol.61
, pp. 1392-1405
-
-
Sanyal, A.J.1
Friedman, S.L.2
McCullough, A.J.3
Dimick-Santos, L.4
-
124
-
-
84889634755
-
Systematic review with meta-analysis: Non-alcoholic steatohepatitis - A case for personalised treatment based on pathogenic targets
-
Younossi ZM, Reyes MJ, Mishra A, Mehta R, Henry L: Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Aliment Pharmacol Ther 2014; 39: 3-14.
-
(2014)
Aliment Pharmacol Ther
, vol.39
, pp. 3-14
-
-
Younossi, Z.M.1
Reyes, M.J.2
Mishra, A.3
Mehta, R.4
Henry, L.5
-
126
-
-
84930654328
-
Current efforts and trends in the treatment of NASH
-
Ratziu V, Goodman Z, Sanyal A: Current efforts and trends in the treatment of NASH. J Hepatol 2015; 62:S65-S75.
-
(2015)
J Hepatol
, vol.62
, pp. S65-S75
-
-
Ratziu, V.1
Goodman, Z.2
Sanyal, A.3
-
127
-
-
3242745192
-
Effects of rosigli-tazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
-
Tiikkainen M, Häkkinen AM, Korsheninnikova E, Nyman T, Makimattila S, Yki-Järvinen H: Effects of rosigli-tazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 2004;53: 2169-2176.
-
(2004)
Diabetes
, vol.53
, pp. 2169-2176
-
-
Tiikkainen, M.1
Häkkinen, A.M.2
Korsheninnikova, E.3
Nyman, T.4
Makimattila, S.5
Yki-Järvinen, H.6
-
128
-
-
84864072013
-
Metformin prevents liver tumori-genesis by inhibiting pathways driving hepatic lipogenesis
-
Bhalla K, Hwang BJ, Dewi RE, Twaddel W, Goloubeva OG, Wong KK, et al: Metformin prevents liver tumori-genesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prev Res (Phila) 2012; 5: 544-552.
-
(2012)
Cancer Prev Res (Phila)
, vol.5
, pp. 544-552
-
-
Bhalla, K.1
Hwang, B.J.2
Dewi, R.E.3
Twaddel, W.4
Goloubeva, O.G.5
Wong, K.K.6
-
129
-
-
84863601615
-
Metformin for liver cancer prevention in patients with type 2 diabetes: A systematic review and metaanalysis
-
Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE: Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and metaanalysis. J Clin Endocrinol Metab 2012; 97: 2347-2353.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 2347-2353
-
-
Zhang, Z.J.1
Zheng, Z.J.2
Shi, R.3
Su, Q.4
Jiang, Q.5
Kip, K.E.6
-
130
-
-
84859003663
-
Effects of glucagonlike peptide-1 receptor agonists on weight loss: Systematic review and meta-analyses of randomised controlled trials
-
Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL: Effects of glucagonlike peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ 2012; 344:d7771.
-
(2012)
BMJ
, vol.344
, pp. d7771
-
-
Vilsboll, T.1
Christensen, M.2
Junker, A.E.3
Knop, F.K.4
Gluud, L.L.5
-
131
-
-
84879242918
-
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
-
Hoofnagle JH, Van Natta ML, Kleiner DE, Clark JM, Kowdley KV, Loomba R, et al: Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2013; 38: 134-143.
-
(2013)
Aliment Pharmacol Ther
, vol.38
, pp. 134-143
-
-
Hoofnagle, J.H.1
Van Natta, M.L.2
Kleiner, D.E.3
Clark, J.M.4
Kowdley, K.V.5
Loomba, R.6
-
132
-
-
33847378451
-
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis
-
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297: 842-857.
-
(2007)
JAMA
, vol.297
, pp. 842-857
-
-
Bjelakovic, G.1
Nikolova, D.2
Gluud, L.L.3
Simonetti, R.G.4
Gluud, C.5
-
133
-
-
84881317939
-
Effects of Vitamin E on stroke subtypes: Meta-analysis of randomised controlled trials
-
Schurks M, Glynn RJ, Rist PM, Tzourio C, Kurth T: Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 2010; 341:c5702.
-
(2010)
BMJ
, vol.341
, pp. c5702
-
-
Schurks, M.1
Glynn, R.J.2
Rist, P.M.3
Tzourio, C.4
Kurth, T.5
-
134
-
-
80053954605
-
Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
-
Klein EA, Thompson Jr IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al: Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306: 1549-1556.
-
(2011)
JAMA
, vol.306
, pp. 1549-1556
-
-
Klein, E.A.1
Thompson, I.M.2
Tangen, C.M.3
Crowley, J.J.4
Lucia, M.S.5
Goodman, P.J.6
-
135
-
-
84880664792
-
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease
-
Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, et al: Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastro-enterology 2013; 145:e571.
-
(2013)
Gastro-enterology
, vol.145
, pp. e571
-
-
Mudaliar, S.1
Henry, R.R.2
Sanyal, A.J.3
Morrow, L.4
Marschall, H.U.5
Kipnes, M.6
-
136
-
-
84858703583
-
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
-
Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J: Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012; 56: 944-951.
-
(2012)
J Hepatol
, vol.56
, pp. 944-951
-
-
Parker, H.M.1
Johnson, N.A.2
Burdon, C.A.3
Cohn, J.S.4
O'Connor, H.T.5
George, J.6
-
137
-
-
84939268765
-
Statin use and nonalcoholic steatohepatitis in at risk individuals
-
Dongiovanni P, Petta S, Mannisto V, Margherita Mancina R, Pipitone R, Karja V, et al: Statin use and nonalcoholic steatohepatitis in at risk individuals. J Hepatol 2015;doi: 10.1016/j.jhep.2015.05.006.
-
(2015)
J Hepatol
-
-
Dongiovanni, P.1
Petta, S.2
Mannisto, V.3
Margherita Mancina, R.4
Pipitone, R.5
Karja, V.6
-
138
-
-
34249098685
-
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: Evidence from a case-control study
-
Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, et al: Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 2007; 102: 1251-1258.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 1251-1258
-
-
Valenti, L.1
Fracanzani, A.L.2
Dongiovanni, P.3
Bugianesi, E.4
Marchesini, G.5
Manzini, P.6
-
139
-
-
75349091707
-
Pediatric non-alcoholic fatty liver disease: Preventive and therapeutic value of lifestyle intervention
-
Nobili V, Alisi A, Raponi M: Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol 2009; 15: 6017-6022.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 6017-6022
-
-
Nobili, V.1
Alisi, A.2
Raponi, M.3
-
140
-
-
84908362139
-
Review article: The management of paediatric nonalcoholic fatty liver disease
-
Mitchel EB, Lavine JE: Review article: the management of paediatric nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2014; 40: 1155-1170.
-
(2014)
Aliment Pharmacol Ther
, vol.40
, pp. 1155-1170
-
-
Mitchel, E.B.1
Lavine, J.E.2
-
141
-
-
70350241227
-
The natural history of non-alcoholic fatty liver disease in children: A follow-up study for up to 20 years
-
Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009; 58: 1538-1544.
-
(2009)
Gut
, vol.58
, pp. 1538-1544
-
-
Feldstein, A.E.1
Charatcharoenwitthaya, P.2
Treeprasertsuk, S.3
Benson, J.T.4
Enders, F.B.5
Angulo, P.6
-
142
-
-
84900335025
-
Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes
-
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al: Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014; 370: 2002-2013.
-
(2014)
N Engl J Med
, vol.370
, pp. 2002-2013
-
-
Schauer, P.R.1
Bhatt, D.L.2
Kirwan, J.P.3
Wolski, K.4
Brethauer, S.A.5
Navaneethan, S.D.6
-
143
-
-
84926122690
-
Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: A 5-year controlled longitudinal study
-
Discussion 898-899
-
Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V, et al: Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 2014; 260: 893-898, Discussion 898-899.
-
(2014)
Ann Surg
, vol.260
, pp. 893-898
-
-
Caiazzo, R.1
Lassailly, G.2
Leteurtre, E.3
Baud, G.4
Verkindt, H.5
Raverdy, V.6
-
144
-
-
84938070225
-
Bariatric surgery reduces features of non-alcoholic steatohepatitis in morbidly obese patients
-
Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J, et al: Bariatric surgery reduces features of non-alcoholic steatohepatitis in morbidly obese patients. Gastroenterology 2015; 149: 377-388.
-
(2015)
Gastroenterology
, vol.149
, pp. 377-388
-
-
Lassailly, G.1
Caiazzo, R.2
Buob, D.3
Pigeyre, M.4
Verkindt, H.5
Labreuche, J.6
-
145
-
-
80053581540
-
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
-
Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA: Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249-1253.
-
(2011)
Gastroenterology
, vol.141
, pp. 1249-1253
-
-
Charlton, M.R.1
Burns, J.M.2
Pedersen, R.A.3
Watt, K.D.4
Heimbach, J.K.5
Dierkhising, R.A.6
-
146
-
-
84893953781
-
Outcomes of liver transplantation for nonalcoholic steatohepatitis: A systematic review and meta-analysis
-
Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014; 12:e391.
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, pp. e391
-
-
Wang, X.1
Li, J.2
Riaz, D.R.3
Shi, G.4
Liu, C.5
Dai, Y.6
-
147
-
-
84864246433
-
Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: A single-center experience
-
Heuer M, Kaiser GM, Kahraman A, Banysch M, Saner FH, Mathe Z, et al: Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. Digestion 2012; 86: 107-113.
-
(2012)
Digestion
, vol.86
, pp. 107-113
-
-
Heuer, M.1
Kaiser, G.M.2
Kahraman, A.3
Banysch, M.4
Saner, F.H.5
Mathe, Z.6
-
148
-
-
84858701127
-
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients
-
Sebagh M, Samuel D, Antonini TM, Coilly A, Degli Esposti D, Roche B, et al: Twenty-year protocol liver biopsies: invasive but useful for the management of liver recipients. J Hepatol 2012; 56: 840-847.
-
(2012)
J Hepatol
, vol.56
, pp. 840-847
-
-
Sebagh, M.1
Samuel, D.2
Antonini, T.M.3
Coilly, A.4
Degli Esposti, D.5
Roche, B.6
|